2026 Scott A. Summers: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	62	10545	9732	4578	4113	148	22133

Overview

Scott A. Summers is affiliated with the University of Utah in the United States. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. The subfields of their work include Molecular Biology, Cancer Research, Physiology, Epidemiology, and Surgery.

The scientist's research covers several key topics:

Sphingolipid Metabolism and Signaling
Peroxisome Proliferator-Activated Receptors
Cancer, Lipids, and Metabolism
Liver Disease Diagnosis and Treatment
Lipid Membrane Structure and Behavior
Metabolism, Diabetes, and Cancer
Diet, Metabolism, and Disease

A selection of recent papers authored or co-authored by Summers includes:

Ceramides and other sphingolipids as drivers of cardiovascular disease, 2021, Nature Reviews Cardiology
Ceramides in Metabolism: Key Lipotoxic Players, 2020, Annual Review of Physiology
Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome, 2022, Obesity
Reign in the membrane: How common lipids govern mitochondrial function, 2020, Current Opinion in Cell Biology
Adipocyte Ceramides-The Nexus of Inflammation and Metabolic Disease, 2020, Frontiers in Immunology

Summers has frequently collaborated with several co-authors, including:

William L. Holland
J. Alan Maschek
James E. Cox
Rebekah J. Nicholson
Mary C. Playdon

The scientist's work has been published in a variety of venues, with recurring publications in:

bioRxiv (Cold Spring Harbor Laboratory)
Journal of the American Society of Nephrology
Scientific Reports
Frontiers in Endocrinology
Diabetes

Best Publications

Expression of a Constitutively Active Akt Ser/Thr Kinase in 3T3-L1 Adipocytes Stimulates Glucose Uptake and Glucose Transporter 4 Translocation

Aimee D. Kohn;Scott A. Summers;Morris J. Birnbaum;Richard A. Roth

1651
Citations
Inhibition of Ceramide Synthesis Ameliorates Glucocorticoid-, Saturated-Fat-, and Obesity-Induced Insulin Resistance

William L. Holland;Joseph T. Brozinick;Li Ping Wang;Eric D. Hawkins

1354
Citations
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin

William L. Holland;Russell A. Miller;Zhao V. Wang;Kai Sun

990
Citations
Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice.

William L. Holland;Benjamin T. Bikman;Li Ping Wang;Guan Yuguang

793
Citations
A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids.

Jose Antonio Chavez;Trina A. Knotts;Li Ping Wang;Guibin Li

720
Citations
A Ceramide-Centric View of Insulin Resistance

Jose A. Chavez;Scott A. Summers;Scott A. Summers

649
Citations
Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism

William L. Holland;Scott A. Summers

624
Citations
Ceramides – Lipotoxic Inducers of Metabolic Disorders

Bhagirath Chaurasia;Scott A. Summers

590
Citations
Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes.

Jose Antonio Chavez;Scott A Summers

575
Citations
Regulation of Insulin-Stimulated Glucose Transporter GLUT4 Translocation and Akt Kinase Activity by Ceramide

Scott A. Summers;Luis A. Garza;Honglin Zhou;Morris J. Birnbaum

562
Citations
Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B.

Suzanne Stratford;Kyle L. Hoehn;Feng Liu;Scott A. Summers

485
Citations
Ceramides as modulators of cellular and whole-body metabolism.

Benjamin T. Bikman;Scott A. Summers

471
Citations
CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance

Suryaprakash Raichur;Siew Tein Wang;Puck Wee Chan;Ying Li

450
Citations
INHIBITION OF AKT KINASE BY CELL-PERMEABLE CERAMIDE AND ITS IMPLICATIONS FOR CERAMIDE-INDUCED APOPTOSIS

Honglin Zhou;Scott A. Summers;Morris J. Birnbaum;Randall N. Pittman

440
Citations
Sphingolipids and phospholipids in insulin resistance and related metabolic disorders

Peter J. Meikle;Scott A. Summers

385
Citations
Construction and Characterization of a Conditionally Active Version of the Serine/Threonine Kinase Akt

Aimee D. Kohn;Andreas Barthel;Kristina S. Kovacina;Annegret Boge

378
Citations
Caffeine stimulates hepatic lipid metabolism by the autophagy‐lysosomal pathway in mice

Rohit A. Sinha;Benjamin L. Farah;Brijesh K. Singh;Monowarul M. Siddique

365
Citations
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis.

Bhagirath Chaurasia;Trevor S. Tippetts;Rafael Mayoral Monibas;Jinqi Liu

347
Citations
Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy

Rohit Anthony Sinha;Seo Hee You;Jin Zhou;Mobin M. Siddique

277
Citations
The Role of Glycogen Synthase Kinase 3β in Insulin-stimulated Glucose Metabolism

Scott A. Summers;Aimee W. Kao;Aimee D. Kohn;Gillian S. Backus

269
Citations